Efficacy and mechanism of Guizhi Tongluo Tablets in alleviating atherosclerosis by inhibiting CD72hi macrophages.
10.19540/j.cnki.cjcmm.20241107.707
- Author:
Xing-Ling HE
1
;
Si-Jing LI
1
;
Zi-Ru LI
1
;
Dong-Hua LIU
1
;
Xiao-Jiao ZHANG
1
;
Huan HE
1
;
Xiao-Ming DONG
2
;
Wen-Jie LONG
2
;
Wei-Wei ZHANG
3
;
Hui-Li LIAO
2
;
Lu LU
4
;
Zhong-Qi YANG
5
;
Shi-Hao NI
1
Author Information
1. State Key Laboratory of Traditional Chinese Medicine Syndrome, the First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510407, China Lingnan Medical Research Center, Guangzhou University of Chinese Medicine Guangzhou 510407, China Guangdong Clinical Research Institute of Chinese Medicine Guangzhou 510407, China.
2. Department of Geriatrics, the First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510407, China Guangdong Clinical Research Institute of Chinese Medicine Guangzhou 510407, China.
3. Shenzhen Bao'an Traditional Chinese Medicine Hospital Group Shenzhen 518133, China.
4. Lingnan Medical Research Center, Guangzhou University of Chinese Medicine Guangzhou 510407, China Guangdong Clinical Research Institute of Chinese Medicine Guangzhou 510407, China.
5. State Key Laboratory of Traditional Chinese Medicine Syndrome, the First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510407, China Department of Geriatrics, the First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510407, China Lingnan Medical Research Center, Guangzhou University of Chinese Medicine Guangzhou 510407, China Guangdong Clinical Research Institute of Chinese Medicine Guangzhou 510407, China.
- Publication Type:Journal Article
- Keywords:
CD72hi macrophages;
Guizhi Tongluo Tablets;
atherosclerosis;
single-cell sequencing;
stasis and toxin
- MeSH:
Animals;
Drugs, Chinese Herbal/administration & dosage*;
Atherosclerosis/immunology*;
Mice;
Mice, Inbred C57BL;
Macrophages/immunology*;
Male;
Humans;
Apolipoproteins E/genetics*;
Tablets;
Tumor Necrosis Factor-alpha/genetics*;
Apoptosis/drug effects*;
Interleukin-1beta/genetics*;
Interleukin-6/genetics*;
Disease Models, Animal;
Mice, Knockout
- From:
China Journal of Chinese Materia Medica
2025;50(5):1298-1309
- CountryChina
- Language:Chinese
-
Abstract:
This study investigates the effect and underlying mechanism of Guizhi Tongluo Tablets(GZTL) in treating atherosclerosis(AS) in a mouse model. Apolipoprotein E-knockout(ApoE~(-/-)) mice were randomly assigned to the following groups: model, high-, medium-, and low-dose GZTL, and atorvastatin(ATV), and age-matched C57BL/6J mice were selected as the control group. ApoE~(-/-) mice in other groups except the control group were fed with a high-fat diet for the modeling of AS and administrated with corresponding drugs via gavage for 8 weeks. General conditions, signs of blood stasis, and body mass of mice were monitored. Aortic plaques and their stability were assessed by hematoxylin-eosin, Masson, and oil red O staining. Serum levels of total cholesterol(TC), triglycerides(TG), and low-density lipoprotein cholesterol(LDL-C) were measured by biochemical assays, and those of interleukin-1β(IL-1β), tumor necrosis factor-α(TNF-α), and interleukin-6(IL-6) were determined via enzyme-linked immunosorbent assay. Apoptosis was assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling(TUNEL). Single-cell RNA sequencing(scRNA-seq) was employed to analyze the differential expression of CD72hi macrophages(CD72hi-Mφ) in the aortas of AS patients and mice. The immunofluorescence assay was employed to visualize CD72hi-Mφ expression in mouse aortic plaques, and real-time fluorescence quantitative PCR was utilized to determine the mRNA levels of IL-1β, TNF-α, and IL-6 in the aorta. The results demonstrated that compared with the control group, the model group exhibited significant increases in body mass, aortic plaque area proportion, necrotic core area proportion, and lipid deposition, a notable decrease in collagen fiber content, and an increase in apoptosis. Additionally, the model group showcased elevated serum levels of TC, TG, LDL-C, IL-1β, TNF-α, and IL-6, alongside marked upregulations in the mRNA levels of IL-1β, TNF-α, and IL-6 in the aorta. In comparison with the model group, the GZTL groups and the ATV group showed a reduction in body mass, and the medium-and high-dose GZTL groups and the ATV group demonstrated reductions in aortic plaque area proportion, necrotic core area proportion, and lipid deposition, an increase in collagen fiber content, and a decrease in apoptosis. Furthermore, the treatment goups showcased lowered serum levels of TC, TG, LDL-C, IL-1β, TNF-α, and IL-6. The data of scRNA-seq revealed significantly elevated CD72hi-Mφ signaling in carotid plaques of AS patients compared with that in the normal arterial tissue. Animal experiments confirmed that CD72hi-Mφ expression, along with several pro-inflammatory cytokines, was significantly upregulated in the aortas of AS mice, which were downregulated by GZTL treatment. In conclusion, GZTL may alleviate AS by inhibiting CD72hi-Mφ activity.
